ETrade Capital Management’s Globus Medical GMED Stock Holding History

ETrade Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-35,103	Closed	-$837K	–	541
2016 Q2	$837K	Sell	35,103 -16	-0%	-$384	0.04%	246
2016 Q1	$834K	Buy	35,119 +1,934	+6%	+$47.3K	0.05%	240
2015 Q4	$923K	Buy	33,185 +2,578	+8%	+$64.7K	0.05%	201
2015 Q3	$632K	Buy	30,607 +4,834	+19%	+$122K	0.04%	262
2015 Q2	$662K	Buy	25,773 +2,546	+11%	+$64.5K	0.04%	245
2015 Q1	$586K	Buy	23,227 +2,240	+11%	+$54.6K	0.03%	263
2014 Q4	$499K	Buy	20,987 +3,705	+21%	+$82K	0.03%	300
2014 Q3	$340K	Buy	17,282 +8,141	+89%	+$167K	0.02%	344
2014 Q2	$219K	Buy	9,141 +5,063	+124%	+$122K	0.01%	393
2014 Q1	$108K	Buy	+4,078	New	+$96.9K	0.01%	453

Other funds holding GMED

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ETrade Capital Management's GMED Position: Q3 2016 in Review

ETrade Capital Management sold out of Globus Medical (GMED) in Q3 2016, closing a stake of 35,103 shares — an estimated $837K sold.

ETrade Capital Management first reported a position in GMED in Q1 2014 and held it in 10 quarters. The position peaked at $923K in Q4 2015. 196 funds tracked by Wall St. Rank hold GMED as of Q3 2016.

ETrade Capital Management reported no remaining Globus Medical position as of Q3 2016 after selling out during the quarter.
ETrade Capital Management sold 35,103 Globus Medical shares in Q3 2016, an estimated $837K.
ETrade Capital Management first reported a position in Globus Medical in Q1 2014 and held it in 10 quarters.
ETrade Capital Management's Globus Medical position peaked at $923K in Q4 2015.
196 funds tracked by Wall St. Rank held Globus Medical as of Q3 2016.

Based on ETrade Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.